Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: A longitudinal study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 6, 2008, Pages 646-649

  Monami, Matteo ^a   Lamanna, Caterina ^a   Balzi, Daniela ^b   Bartalucci, Francesca ^a   Melani, Cecilia ^b   Masotti, Giulio ^a   Marchionni, Niccolò ^a   Mannucci, Edoardo ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Local Health Unit 10   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Advanced age; Cardiovascular mortality; Diabetes mellitus; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; COMPARATIVE STUDY; LONGITUDINAL STUDY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 50949113456     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.6.646     Document Type: Article

References (23)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366:1059-1062.
3. Bonora E, Kiechl S, Willeit J, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes. 2004;53:1782-1789.
4. Bruno G, Merletti F, Biggeri A, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care. 2004;27:2689-2694.
5. Hillier TA, Rizzo JH, Pedula KL, et al. Increased mortality associated with the metabolic syndrome in older women with diabetes. Diabetes Care. 2005;28:2258-2260.
6. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
7. Monami M, Marchionni N, Masotti G, Mannucci E. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obes Metab. 2006;9:350-353.
8. Monami M, Lambertucci L, Ungar A, et al. Is the third component of metabolic syndrome really predictive of outcome in type 2 diabetic patients? Diabetes Care. 2006;29:2515-2517.
9. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care. 2006;29:1363-1369.
10. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria and metabolic syndrome as predictors of cardiovascular death in nondiabetic and type 2 diabetic men and women. Diabetologia. 2006;49:56-65.
11. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112:666-673.
12. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309-314.
13. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004;110:1251-1257.
14. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
15. Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 2003;26:1251-1257.
16. Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2004;93:136-141.
17. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706-713.
18. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066-1076.
19. Eberly LE, Prineas R, Cohen JD, et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care. 2006;29:123-130.
20. Chalmers J, MacMahon S, Mancia G, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21:1009-1060.
21. Blackburn H. Classification of the electrocardiogram for population studies: Minnesota code. J Electrocardiol. 1969;2:305-310.
22. Charlson M, Szatrowski T, Peterson T, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
23. Molarius A, Seidell JC, Visscher TL, Hofman A. Misclassification of high-risk older subjects using waist action levels established for young and middle-aged adults - results from the Rotterdam Study. J Am Geriatr Soc. 2000;48:1638-1645.